We are pleased to invite a select group of investors to an exclusive, closed-door Financial Deep Dive on July 8, focused on Glucowear — the next-generation, pain-free continuous glucose monitoring technology developed by Afon Technology Ltd.

This session will offer a comprehensive overview of the company's financial position, commercial strategy, growth trajectory, and fundraising plans. Members of the senior leadership team will present key financial metrics, provide updates on clinical and regulatory progress, outline the manufacturing strategy, and detail the roadmap toward commercialization.

The event will take place as a two-hour live video session beginning at 8:00 AM EST, structured to facilitate in-depth discussion with the founding and leadership team.